(R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-(cyclohexylcarbamoyloxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

ID: ALA4783384

PubChem CID: 162666181

Max Phase: Preclinical

Molecular Formula: C31H51NO4

Molecular Weight: 501.75

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(=O)NC5CCCCC5)CC[C@]4(C)[C@H]3CC[C@]12C

Standard InChI:  InChI=1S/C31H51NO4/c1-20(9-14-28(33)34)25-12-13-26-24-11-10-21-19-23(36-29(35)32-22-7-5-4-6-8-22)15-17-30(21,2)27(24)16-18-31(25,26)3/h20-27H,4-19H2,1-3H3,(H,32,35)(H,33,34)/t20-,21-,23-,24+,25-,26+,27+,30+,31-/m1/s1

Standard InChI Key:  PBHFYWLQYQDDAL-GOBNXBNUSA-N

Molfile:  

 
     RDKit          2D

 41 45  0  0  0  0  0  0  0  0999 V2000
   12.6169  -20.0501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6169  -20.8673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3222  -21.2717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3222  -19.6374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0275  -20.0501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0240  -20.8673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7261  -21.2766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4361  -20.8733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7330  -19.6422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4396  -20.0609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4565  -18.4212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7384  -18.8232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1631  -18.8399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1498  -19.6586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9243  -19.9243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4163  -19.2697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9458  -18.5996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1416  -20.4752    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   14.7260  -20.4587    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   14.0202  -19.2329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0161  -21.6803    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   15.4317  -19.2411    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   16.1581  -18.0195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2109  -17.8266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0129  -17.6697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6741  -17.2105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5498  -18.2858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3518  -18.1289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8887  -18.7450    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.6169  -17.3559    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7595  -18.5973    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   11.9098  -21.2769    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2015  -20.8693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4944  -21.2789    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2003  -20.0521    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7861  -20.8714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7874  -20.0577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0831  -19.6502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3736  -20.0564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3728  -20.8745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0816  -21.2865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  5  9  1  0
  6  7  1  0
  7  8  1  0
  8 10  1  0
  9 10  1  0
  9 12  1  0
 10 14  1  0
 13 11  1  0
 11 12  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
 14 18  1  6
  9 19  1  6
  5 20  1  1
  6 21  1  1
 10 22  1  1
 13 23  1  1
 17 24  1  0
 24 25  1  0
 24 26  1  6
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
 17 31  1  6
  2 32  1  6
 32 33  1  0
 33 34  1  0
 33 35  2  0
 34 36  1  0
 36 37  1  0
 36 41  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4783384

    ---

Associated Targets(non-human)

Epha2 Ephrin type-A receptor 2 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 501.75Molecular Weight (Monoisotopic): 501.3818AlogP: 7.57#Rotatable Bonds: 6
Polar Surface Area: 75.63Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.79CX Basic pKa: CX LogP: 7.15CX LogD: 4.59
Aromatic Rings: Heavy Atoms: 36QED Weighted: 0.39Np Likeness Score: 1.44

References

1. Incerti M,Russo S,Corrado M,Giorgio C,Ballabeni V,Chiodelli P,Rusnati M,Scalvini L,Callegari D,Castelli R,Vacondio F,Ferlenghi F,Tognolini M,Lodola A.  (2020)  Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties.,  189  [PMID:32000051] [10.1016/j.ejmech.2020.112083]

Source